[HTML][HTML] Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer …
X Song, A Xiong, F Wu, X Li, J Wang… - … for Immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Immunotherapy for malignant tumors has made great progress, but many
patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in …
patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in …
Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated …
X Song, A Xiong, F Wu, X Li, J Wang… - Journal for …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Immunotherapy for malignant tumors has made great progress, but many
patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in …
patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in …
Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated …
X Song, A Xiong, F Wu, X Li, J Wang… - Journal for …, 2023 - search.proquest.com
Background Immunotherapy for malignant tumors has made great progress, but many
patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in …
patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in …
[HTML][HTML] Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer …
X Song, A Xiong, F Wu, X Li, J Wang, T Jiang… - … for ImmunoTherapy of …, 2023 - jitc.bmj.com
Background Immunotherapy for malignant tumors has made great progress, but many
patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in …
patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in …
Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated …
X Song, A Xiong, F Wu, X Li, J Wang… - … for Immunotherapy of …, 2023 - europepmc.org
Background Immunotherapy for malignant tumors has made great progress, but many
patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in …
patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in …
Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated …
X Song, A Xiong, F Wu, X Li, J Wang… - … for Immunotherapy of …, 2023 - europepmc.org
Immunotherapy for malignant tumors has made great progress, but many patients do not
benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in-depth …
benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in-depth …